Longevity's Real Moonshots: Gene Editing, Early Detection and the 2040 Question
In this live panel, Siim Land and a German longevity clinic founder look past supplements and wearables to the technologies that could actually change the curve: multiomic datasets that flag disease years before it appears, and gene editing of the handful of genes already linked to exceptional lifespan. Both agree that these are a decade or two away and that the unglamorous basics still carry the most leverage today. The panel closes on the part longevity conversations usually skip: purpose, mindset and social connection.
Overview
This panel discussion opens with two very different routes into longevity. For the clinic founder, it is about maximizing healthy years so he can play football with his grandchildren; for Siim Land, it began with a grandfather who died of colon cancer at 36 and grew into a fascination with aging as a hard scientific problem. From there the conversation moves through what clinics can already detect — automated skin lesion screening and retina scans that surface cardiovascular risk — and why fragmentation, not technology, is the current bottleneck.
Siim explains his own measurement philosophy: comprehensive blood work, bone density and occasional imaging, but no daily wearable tracking, since his routine is stable enough that little would change. The middle of the panel turns to repair versus replacement, with lab-grown skin already in clinical use and full cultured organs likely more than a decade out, alongside the unsettling question of what remains of a person once every cell has been replaced. Both guests name their moonshots: longitudinal multiomic datasets that could predict a specific disease risk years in advance, and targeted gene therapy for genes such as APOE2, FOXO3 and IGF-1 that are already associated with longer, healthier lives.
They temper this with realism — current gene therapies have thin evidence, and a 70-year-old in 2040 is more likely to resemble a healthy 50-year-old today than an Olympic sprinter. The practical advice both give is identical: establish a health baseline, intervene, then retest. The discussion ends with an audience question about repressed emotions that shifts the room toward purpose, optimism and community as the most underrated longevity factors of all.
Key quotes
5Longevity for me is not about living forever, but to maximize my healthy lifespan.
Exercising and taking some supplements are not going to make you live to 150 or 200. You will need to do something more dramatic and more powerful, such as gene editing.
You can take 1,000 data points, but if you're not able to translate them into three or four clear action points, you lose the people.
It's not about just making people live longer, it's about actually making them healthier.
The two greatest indicators of long life are: do you have purpose in your life, and how strong are your social connections.
Key ideas
9Longevity means healthy years, not endless ones
Both panelists reject immortality as the goal and frame longevity as maximizing the years you can still move, travel and play. The levers they name first are the ordinary ones: sleep, nutrition and regular training.
Prevention born from personal loss
Siim Land traces his interest to a grandfather who died of colon cancer at 36, which pushed him from fitness toward preventive health. His anthropology background reframed aging as one of the hardest open problems in science, unlike obesity or diabetes where the mechanisms are largely understood.
Early detection is advancing but fragmented
Clinics already use automated image analysis to flag suspicious skin lesions and retina scans that surface cardiovascular risk. The limitation is that these tools sit in silos; the breakthrough will come when they are combined into one picture of a person.
Measure deeply, not constantly
Siim tracks blood work, bone density, VO2 max and occasional imaging, but skips daily sleep and glucose tracking. His reasoning is practical: a stable routine produces few surprises, and a ring you forget to charge collects no data anyway.
Repair is here, replacement is not
Lab-grown skin is already in clinical use, but that is repair rather than replacement. Growing functional transplantable organs is estimated to be at least another decade away, and whole-body replacement remains a thought experiment.
Gene editing as the first real lever
Siim points to a widely discussed study in China where monkeys treated with genetically engineered human stem cells showed reduced biological age scores. He expects the earliest real therapies to be modest gene edits combined with stem cells or exosomes, not any single magic intervention.
The consciousness problem nobody has solved
If every organ and cell were eventually replaced and only the brain remained, would the person still be themselves? Siim notes we do not know what creates consciousness or where it resides, which makes the most extreme replacement scenarios philosophically unresolved.
Predicting disease before it appears
The clinic's moonshot is longitudinal multiomic datasets deep enough to flag that a specific person is likely to develop a specific disease at a specific point in the future. The founder estimates roughly ten to fifteen years for this to mature.
The handful of genes we already know
APOE4 is well established as raising Alzheimer's and heart disease risk, while APOE2 carriers show lower rates and greater overall longevity. Together with FOXO3 and IGF-1, these are described as the low-hanging fruit for future gene therapy — though today's available therapies still have very limited evidence behind them.
Practical takeaways
6- 1
Establish your baseline first 33:20
Before chasing interventions, find out where you actually stand — metabolic health, bone density, lipids, blood pressure. Both panelists name this as the single most valuable first step.
- 2
Intervene, then retest 33:50
Choose a suitable intervention for your weakest area, then measure again to see whether it moved. If it worked, move on; if not, change the intervention rather than assuming.
- 3
Keep supplement expectations modest 34:30
Compounds like resveratrol, spermidine and NMN may have some effects, but the panel is blunt that they will not make anyone immortal and that many products on the shelf do very little.
- 4
Don't skip the boring basics 35:00
Sleep, a healthy diet and regular training are called the most underrated tools precisely because they are unexciting and available to everyone — that is where the biggest leverage still sits.
- 5
Consider a regular sauna habit 35:20
Siim names sauna as genuinely underrated, pointing to associations with cardiovascular benefits, blood pressure and Alzheimer's risk beyond the standard basics.
- 6
Protect purpose and connection 35:40
Optimists have been observed to live meaningfully longer, and purpose plus strong social ties are described as the two greatest indicators of a long life. Treat them as part of the protocol, not a soft extra.
Topics & chapters
15Why longevity matters to each of them
Two openings: maximizing healthy years to keep up with grandchildren, and the basics as the biggest available leverage today.
From family loss to preventive health
Siim Land explains how a grandfather's early death and a background in anthropology led him to aging as a scientific problem.
Early detection in the clinic today
Automated skin screening and retina scans that reveal heart risk — and why fragmentation still holds the field back.
How Siim actually measures himself
Comprehensive blood work and imaging over constant wearable tracking, with a candid explanation of why.
Cell and gene therapy today
The panel discusses the small number of people who have taken gene therapy for anti-aging purposes so far.
Repair versus replacement
Lab-grown skin is already used clinically, while growing full organs is estimated to be at least a decade away.
Gene editing and the monkey study
Turning longevity genes on and harmful ones off, plus the engineered stem cell study that lowered biological age scores in monkeys.
How long do you actually want to live?
An audience show of hands, living across three centuries, and the idea of reaching immortality in order to choose.
What people really want from a clinic
Clients arrive overwhelmed and want guidance, trust and simplicity — a thousand data points reduced to a few clear actions.
From the few to the many
The Tesla principle applied to longevity medicine: early revenue funds the scaling that eventually broadens access.
Healthspan as the public priority
Why governments benefit from healthier citizens rather than merely longer-living ones, and what that means for chronic disease burden.
Moonshot one: seeing disease years ahead
Longitudinal multiomic datasets that could flag a specific risk before symptoms, estimated at ten to fifteen years out.
Moonshot two: editing longevity genes
APOE2, FOXO3 and IGF-1 as the low-hanging fruit, tempered by how thin the evidence for current gene therapies remains.
A 70-year-old in 2040
Both expect a healthy 70-year-old to resemble today's fifty-something, and explain the idea of longevity escape velocity.
First steps, overhyped and underrated
Baseline testing and retesting as the shared advice, then the panel's candid verdicts on supplements, the basics and sauna.